Sequential therapy with darolutamide in patients with non-metastatic castration-resistant prostate cancer resistant to enzalutamide or apalutamide.

Fujmoto, Saizo; Fujita, Kazutoshi; Nishimoto, Mitsuhisa; Hamaguchi, Mamoru; Kuwahara, Ken; Hashimoto, Mamoru; Adomi, Shogo; Minami, Takafumi; Nozawa, Masahiro; Yoshimura, Kazuhiro; Uemura, Hirotsugu

Fujmoto, Saizo; Fujita, Kazutoshi; Nishimoto, Mitsuhisa; Hamaguchi, Mamoru; Kuwahara, Ken; Hashimoto, Mamoru; Adomi, Shogo; Minami, Takafumi; Nozawa, Masahiro; Yoshimura, Kazuhiro; Uemura, Hirotsugu.

Afiliación

Fujmoto S; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Fujita K; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Nishimoto M; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Hamaguchi M; Department of Urology, Mimihara General Hospital, Sakai, Osaka, Japan.
Kuwahara K; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Hashimoto M; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Adomi S; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Minami T; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Nozawa M; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Yoshimura K; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Uemura H; Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.

Cancer Med ; 12(3): 3176-3179, 2023 02.

Article en En | MEDLINE | ID: mdl-36043427

Asunto(s)

Neoplasias de la Próstata Resistentes a la Castración; Masculino; Humanos; Neoplasias de la Próstata Resistentes a la Castración/tratamiento farmacológico; Antígeno Prostático Específico; Estudios Retrospectivos; Resultado del Tratamiento; Antagonistas de Andrógenos/uso terapéutico

Palabras clave

ARAT; apalutamide; darolutamide; enzalutamide; nmCRPC; prostate cancer

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata Resistentes a la Castración Límite: Humans / Male Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google